ICOS and neoplasm: The expression levels of immune checkpoint genes that negatively regulate T-cell activation, such as PDCD1 and HAVCR2, were significantly increased in SAM/MTA-abundant tumors, whereas the expression of ICOS, an immune checkpoint that promote T-cell activation, was not related to tumor SAM/MTA levels (Supplementary Fig. 3d).